OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.

Medtronic (NYSE: MDT) announced today that it entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal.

In November 2025, Abbott agreed to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact ...

The Medtronic Symplicity Spyral system ablates nerves in the vessel wall to treat hypertension. [Illustration courtesy of Medtronic] Medtronic (NYSE: MDT) + today shared new, long-term data ...

Stereotaxis (NYSE:STXS) today reported its fourth-quarter and full-year financial results ahead of expected growth in 2026.

Verily will integrate data from Samsung’s Galaxy Watch, enabling research sponsors to run real-world studies with re-contactable participants.

View streamlines imaging analysis and visualization by using a suite of AI-enabled tools intended to aid clinical decision making.

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.

SS Innovations (Nasdaq:SSII) announced today that it completed a private placement of common stock worth $18.6 million.

Stryker (NYSE: SYK) announced today that it launched its new SmartHospital platform aimed at transforming care delivery.

Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.